loading

Bioaffinity Technologies Inc Aktie (BIAF) Neueste Nachrichten

pulisher
Apr 18, 2025

bioAffinity Technologies streamlines lung cancer detection test By Investing.com - Investing.com Canada

Apr 18, 2025
pulisher
Apr 17, 2025

bioAffinity Technologies Increases Efficiency of CyPath® Lung Test by Boosting Data Acquisition Throughput by 50% and Reducing Unit Cost - BioSpace

Apr 17, 2025
pulisher
Apr 17, 2025

bioAffinity Technologies streamlines lung cancer detection test - Investing.com

Apr 17, 2025
pulisher
Apr 17, 2025

Bioaffinity Technologies Increases Efficiency Of Cypath Lung Test - marketscreener.com

Apr 17, 2025
pulisher
Apr 17, 2025

Revolutionary Lung Cancer Detection Test Achieves 92% Accuracy While Slashing Costs by 25% - Stock Titan

Apr 17, 2025
pulisher
Apr 17, 2025

ASP Isotopes and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Corsicana Daily Sun

Apr 17, 2025
pulisher
Apr 14, 2025

bioAffinity Technologies Board Member Announces Departure - TipRanks

Apr 14, 2025
pulisher
Apr 14, 2025

CyPath Lung Helped Detect Breast Cancer Recurrence - Medical Product Outsourcing

Apr 14, 2025
pulisher
Apr 11, 2025

Bioaffinity Technologies Files For Resale Of Up To 3.0 Million Shares Of Common Stock By Selling StockholdersSEC Filing - MarketScreener

Apr 11, 2025
pulisher
Apr 07, 2025

bioAffinity Technologies Reports Record Revenue for 2024 - TipRanks

Apr 07, 2025
pulisher
Apr 07, 2025

BIAF Stock Surges Post Improved Earnings and Record 2024 Revenues - Yahoo Finance

Apr 07, 2025
pulisher
Apr 07, 2025

Earnings roundup: Usio back in the black; losses widen at bioAffinity, Wytec - San Antonio Express-News

Apr 07, 2025
pulisher
Apr 06, 2025

bioAffinity Technologies and Can-Fite BioPharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Joplin Globe

Apr 06, 2025
pulisher
Apr 04, 2025

bioAffinity Technologies Stock Price, Quotes and Forecasts | NASDAQ:BIAF - Benzinga

Apr 04, 2025
pulisher
Apr 03, 2025

Best Biotech Stocks To Follow Today – April 1st - Defense World

Apr 03, 2025
pulisher
Apr 02, 2025

Biotech stock bioAffinity Technologies, Inc. (NASDAQ: BIAF) Makes NASDAQ Top Percentage Gainer on News - Investorideas.com

Apr 02, 2025
pulisher
Apr 02, 2025

Take off with BioAffinity Technologies Inc (BIAF): Get ready for trading - Sete News

Apr 02, 2025
pulisher
Apr 02, 2025

bioAffinity Technologies Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Apr 02, 2025
pulisher
Apr 02, 2025

bioAffinity Technologies (NASDAQ:BIAF) Given Hold Rating at Maxim Group - Defense World

Apr 02, 2025
pulisher
Apr 01, 2025

12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga

Apr 01, 2025
pulisher
Apr 01, 2025

Lung cancer spit test fast-tracks a San Antonio biotech company for growth - MSN

Apr 01, 2025
pulisher
Apr 01, 2025

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Apr 01, 2025
pulisher
Apr 01, 2025

Nasdaq Surges 1%; US Construction Spending Rises In February - Benzinga

Apr 01, 2025
pulisher
Apr 01, 2025

Dow Dips Over 400 Points; ISM Manufacturing PMI Falls In March - Benzinga

Apr 01, 2025
pulisher
Apr 01, 2025

What's Going On With BioAffinity Shares Tuesday? - Benzinga

Apr 01, 2025
pulisher
Apr 01, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Apr 01, 2025
pulisher
Mar 31, 2025

bioAffinity Technologies stock hits 52-week low at $0.25 By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

bioAffinity Technologies, Inc. SEC 10-K Report - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

bioAffinity Technologies earnings missed by $0.05, revenue fell short of estimates - Investing.com Canada

Mar 31, 2025
pulisher
Mar 31, 2025

bioAffinity posts 270% revenue rise with Medicare coverage - Investing.com

Mar 31, 2025
pulisher
Mar 31, 2025

bioAffinity Technologies stock hits 52-week low at $0.25 - Investing.com

Mar 31, 2025
pulisher
Mar 31, 2025

bioAffinity posts 270% revenue rise with Medicare coverage By Investing.com - Investing.com India

Mar 31, 2025
pulisher
Mar 31, 2025

Record-Breaking 270% Revenue Surge: bioAffinity's Growth Story Takes Unexpected Turn - Stock Titan

Mar 31, 2025
pulisher
Mar 31, 2025

bioAffinity Technologies Reports Record $9.4 Million Revenue for 2024 - The Joplin Globe

Mar 31, 2025
pulisher
Mar 27, 2025

Case Study: bioAffinity Technologies’ CyPath® Lung Detects Second Primary Lung Cancer in Patient With History of Lung Cancer - BioSpace

Mar 27, 2025
pulisher
Mar 26, 2025

BIOAFFINITY TECHNOLOGIES Earnings Preview: Recent $BIAF Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 26, 2025
pulisher
Mar 26, 2025

Lung Detects Second Primary Lung Cancer in Patient With History of Lung Cancer - Business Wire

Mar 26, 2025
pulisher
Mar 21, 2025

bioAffinity Technologies (NASDAQ:BIAFW) Shares Down 24.3% – Here’s What Happened - Defense World

Mar 21, 2025
pulisher
Mar 20, 2025

bioAffinity stock hits 52-week low at $0.26 amid market challenges - Investing.com Australia

Mar 20, 2025
pulisher
Mar 20, 2025

BioAffinity Technologies Inc (BIAF): An Important Analyst Insights - Stocks Register

Mar 20, 2025
pulisher
Mar 20, 2025

Case Study: bioAffinity Technologies’ Positive CyPath® Lung Result Leads to Detecting Breast Cancer Recurrence - BioSpace

Mar 20, 2025
pulisher
Mar 19, 2025

bioAffinity stock hits 52-week low at $0.26 amid market challenges By Investing.com - Investing.com South Africa

Mar 19, 2025
pulisher
Mar 18, 2025

bioAffinity Technologies Cutting Jobs to Save $4 Million in Operating Costs - MPO-mag

Mar 18, 2025
pulisher
Mar 17, 2025

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Mar 17, 2025
pulisher
Mar 17, 2025

bioAffinity Technologies Announces Pricing of Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million - Business Wire

Mar 17, 2025
pulisher
Mar 13, 2025

Physicians’ Case Studies Offer Insight into Use and Benefit of CyPath® Lung in Avoiding Unnecessary Invasive Procedures and Detecting Lung Cancer - Joplin Globe

Mar 13, 2025
diagnostics_research DGX
$163.03
price up icon 0.05%
diagnostics_research WAT
$321.10
price down icon 0.35%
diagnostics_research LH
$214.88
price down icon 0.51%
$146.16
price down icon 1.59%
diagnostics_research MTD
$996.88
price down icon 2.02%
diagnostics_research IQV
$140.52
price down icon 1.57%
Kapitalisierung:     |  Volumen (24h):